Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jarman

Showing results (111-120 of 189) with videos related to

Pageof 19
Sort By:
Journal of Medicinal Chemistry|May 1, 1988
Analogues of aminoglutethimide based on 1-phenyl-3-azabicyclo[3.1.0]hexane-2,4-dione: selective inhibition of aromatase activityM G Rowlands, M A Bunnett, A B Foster, et al.
Marine Pollution Bulletin|August 23, 2003
Surveillance for previously unmonitored organic contaminants in the San Francisco EstuaryDaniel R Oros, Walter M Jarman, Theresa Lowe, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|April 15, 2011
Adherence to guideline-directed venous thromboembolism prophylaxis among medical and surgical inpatients at 33 academic medical centers in the United StatesAnneliese M Schleyer, Astrid B Schreuder, Kenneth M Jarman, et al.
Psychopharmacology|January 1, 1984
Trazodone--a comparison of single night-time and divided daily dosage regimensD Brooks, W Prothero, N Bouras, et al.
Journal of Medicinal Chemistry|September 1, 1990
Hydroxyperfluoroazobenzenes: novel inhibitors of enzymes of androgen biosynthesisM Jarman, S E Barrie, J J Deadman, et al.
Journal of Medicinal Chemistry|February 1, 1990
Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2C J Springer, P Antoniw, K D Bagshawe, et al.
Experimental Hematology|January 1, 1979
High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastomaT J McElwain, D W Hedley, M Y Gordon, et al.
Biomedical Mass Spectrometry|November 1, 1983
Metabolism of aminoglutethimide in humans: identification of hydroxylaminoglutethimide as an induced metaboliteM Jarman, A B Foster, P E Goss, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1994
Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase)S E Barrie, G A Potter, P M Goddard, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1996
Identification and characterization of limonene metabolites in patients with advanced cancer by liquid chromatography/mass spectrometryG K Poon, D Vigushin, L J Griggs, et al.
Pageof 19

Showing results (111-120 of 189) with videos related to

Sort By:
Pageof 19
Journal of Medicinal Chemistry|May 1, 1988
Analogues of aminoglutethimide based on 1-phenyl-3-azabicyclo[3.1.0]hexane-2,4-dione: selective inhibition of aromatase activityM G Rowlands, M A Bunnett, A B Foster, et al.
Marine Pollution Bulletin|August 23, 2003
Surveillance for previously unmonitored organic contaminants in the San Francisco EstuaryDaniel R Oros, Walter M Jarman, Theresa Lowe, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|April 15, 2011
Adherence to guideline-directed venous thromboembolism prophylaxis among medical and surgical inpatients at 33 academic medical centers in the United StatesAnneliese M Schleyer, Astrid B Schreuder, Kenneth M Jarman, et al.
Psychopharmacology|January 1, 1984
Trazodone--a comparison of single night-time and divided daily dosage regimensD Brooks, W Prothero, N Bouras, et al.
Journal of Medicinal Chemistry|September 1, 1990
Hydroxyperfluoroazobenzenes: novel inhibitors of enzymes of androgen biosynthesisM Jarman, S E Barrie, J J Deadman, et al.
Journal of Medicinal Chemistry|February 1, 1990
Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2C J Springer, P Antoniw, K D Bagshawe, et al.
Experimental Hematology|January 1, 1979
High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastomaT J McElwain, D W Hedley, M Y Gordon, et al.
Biomedical Mass Spectrometry|November 1, 1983
Metabolism of aminoglutethimide in humans: identification of hydroxylaminoglutethimide as an induced metaboliteM Jarman, A B Foster, P E Goss, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1994
Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase)S E Barrie, G A Potter, P M Goddard, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1996
Identification and characterization of limonene metabolites in patients with advanced cancer by liquid chromatography/mass spectrometryG K Poon, D Vigushin, L J Griggs, et al.
Pageof 19